GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $65,000 | +85.7% | 300 | 0.0% | 0.03% | +73.3% |
| Q4 2020 | $35,000 | +20.7% | 300 | 0.0% | 0.02% | +15.4% |
| Q3 2020 | $29,000 | +16.0% | 300 | +50.0% | 0.01% | +8.3% |
| Q2 2020 | $25,000 | -3.8% | 200 | -33.3% | 0.01% | -25.0% |
| Q1 2020 | $26,000 | -16.1% | 300 | 0.0% | 0.02% | +6.7% |
| Q4 2019 | $31,000 | -32.6% | 300 | -25.0% | 0.02% | -31.8% |
| Q3 2019 | $46,000 | -33.3% | 400 | 0.0% | 0.02% | -35.3% |
| Q2 2019 | $69,000 | +3.0% | 400 | 0.0% | 0.03% | 0.0% |
| Q1 2019 | $67,000 | +71.8% | 400 | 0.0% | 0.03% | +61.9% |
| Q4 2018 | $39,000 | -25.0% | 400 | +33.3% | 0.02% | -19.2% |
| Q3 2018 | $52,000 | +271.4% | 300 | +200.0% | 0.03% | +271.4% |
| Q2 2018 | $14,000 | +27.3% | 100 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $11,000 | +37.5% | 100 | +66.7% | 0.01% | +50.0% |
| Q4 2017 | $8,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |